US-based Autonomix Medical has secured a new patent from the Canadian Intellectual Property Office covering its catheter-based tissue monitoring and therapy delivery technology.
The agency issued Canadian Patent No. 3,183,802, titled “Systems, Methods, and Devices for Monitoring and Treatment of Tissues Within and/or Through a Lumen Wall.”
The newly granted patent protects intraluminal systems and instruments that operate from within a bodily lumen.